BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9308250)

  • 21. Coordination of upregulated XBP-1 and downregulated c-myc during myeloma cell differentiation induced by 2-methoxyestradiol.
    Zhou X; Jiang H; Hou J
    Leuk Res; 2007 Sep; 31(9):1259-65. PubMed ID: 17257674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approach.
    French JD; Tschumper RC; Jelinek DF
    Leukemia; 2002 Jun; 16(6):1189-96. PubMed ID: 12040452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity to interferon-alpha and interferon-stimulated gene factor 3 binding activity in human chronic myelogenous leukemia cell line KT-1.
    Yamauchi H; Sakai I; Narumi H; Soga S; Fujita S
    Acta Haematol; 2000; 104(1):1-9. PubMed ID: 11111114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated c-myc messenger RNA in multiple myeloma cell lines.
    Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
    Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
    Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
    J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-kit ligand (SCF) in human multiple myeloma cells.
    Lemoli RM; Fortuna A
    Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
    Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
    Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of a novel myeloma cell line KPMM2 carrying t(3;14)(q21;q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism.
    Goto H; Shimazaki C; Tatsumi T; Yamagata N; Fujita N; Tsuchiya M; Koishihara Y; Ohsugi Y; Nakagawa M
    Leukemia; 1995 Apr; 9(4):711-8. PubMed ID: 7723407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Activation of PKA pathway inhibits reactivity of human myeloma cell line-U266 to IL-6].
    Song J; Li Y; Shen B
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):278-80. PubMed ID: 11783106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic activation of intercellular adhesion molecule 1 (ICAM-1) by TNF-alpha and IFN-gamma is mediated by p65/p50 and p65/c-Rel and interferon-responsive factor Stat1 alpha (p91) that can be activated by both IFN-gamma and IFN-alpha.
    Jahnke A; Johnson JP
    FEBS Lett; 1994 Nov; 354(2):220-6. PubMed ID: 7957928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of aberrant translational control of c-myc in cell lines derived from patients with multiple myeloma.
    Willis AE; Paulin FE; West MJ; Whitney RL
    Curr Top Microbiol Immunol; 1997; 224():269-76. PubMed ID: 9308251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-myc oncogene overexpression down-regulates leukemia inhibitory factor in neuroblastoma.
    Hatzi E; Murphy C; Zoephel A; Ahorn H; Tontsch U; Bamberger AM; Yamauchi-Takihara K; Schweigerer L; Fotsis T
    Eur J Biochem; 2002 Aug; 269(15):3732-41. PubMed ID: 12153570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance.
    Rasmussen T; Knudsen LM; Dahl IM; Johnsen HE
    Leuk Lymphoma; 2003 Oct; 44(10):1761-6. PubMed ID: 14692531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells.
    Verhagen CE; de Boer T ; Smits HH; Verreck FA; Wierenga EA; Kurimoto M; Lammas DA; Kumararatne DS; Sanal O; Kroon FP; van Dissel JT ; Sinigaglia F; Ottenhoff TH
    J Exp Med; 2000 Aug; 192(4):517-28. PubMed ID: 10952721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
    Sancéau J; Hiscott J; Delattre O; Wietzerbin J
    Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth effects of alpha-interferon but not of bombesin or angiotensin II are mediated by activation of STAT proteins.
    Pansky A; Hildebrand P; Heim MH; Eberhard M; Kissel T; Beglinger C
    Eur J Clin Invest; 1998 May; 28(5):398-406. PubMed ID: 9650014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis.
    Fu R; Chen Y; Wang XP; An T; Tao L; Zhou YX; Huang YJ; Chen BA; Li ZY; You QD; Guo QL; Wu ZQ
    Oncotarget; 2016 Feb; 7(5):5715-27. PubMed ID: 26735336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Epstein-Barr virus SM protein induces STAT1 and interferon-stimulated gene expression.
    Ruvolo V; Navarro L; Sample CE; David M; Sung S; Swaminathan S
    J Virol; 2003 Mar; 77(6):3690-701. PubMed ID: 12610144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-6 inhibits apoptosis of human myeloma cell line XG-7 through activation of JAK/STAT pathway and up-regulation of Mcl-1.
    Song L; Li Y; Sun YX; Yu M; Shen BF
    Ai Zheng; 2002 Feb; 21(2):113-6. PubMed ID: 12479056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.
    Thyrell L; Arulampalam V; Hjortsberg L; Farnebo M; Grandér D; Pokrovskaja Tamm K
    Exp Cell Res; 2007 Nov; 313(19):4015-24. PubMed ID: 17880940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.